ctrl K

NKGen Biotech Inc. Common... (NKGN)

NASDAQ: NKGN · Real-Time Price · USD

0.17

0.02 (13.33%)

At close: Apr 29, 2025, 3:56 PM

NKGen Biotech Common Stock Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	26K	117K	351K
Short-Term Investments	n/a	n/a	n/a
Long-Term Investments	n/a	173.49M	171.66M
Other Long-Term Assets	n/a	-173.49M	-171.66M
Receivables	26K	96K	67K
Inventory	n/a	133K	172K
Other Current Assets	313K	4K	22K
Total Current Assets	1.93M	350K	612K
Property-Plant & Equipment	14.46M	15.88M	17.37M
Goodwill & Intangibles	92K	97K	89K
Total Long-Term Assets	14.55M	15.98M	17.46M
Total Assets	16.48M	16.33M	18.07M
Account Payables	11.04M	975K	1.71M
Deferred Revenue	n/a	1.65M	2.35M
Short-Term Debt	9.99M	11.65M	51.15M
Other Current Liabilities	16.77M	346K	303K
Total Current Liabilities	39.45M	14.74M	55.74M
Long-Term Debt	9.93M	n/a	n/a
Other Long-Term Liabilities	25.76M	n/a	n/a
Total Long-Term Liabilities	35.72M	26K	379K
Total Liabilities	75.17M	14.77M	56.12M
Total Debt	19.92M	12.03M	51.97M
Common Stock	2K	33K	14K
Retained Earnings	-162.13M	-79.18M	-52.42M
Comprehensive Income	n/a	n/a	n/a
Shareholders Equity	-58.69M	1.56M	-38.05M
Total Investments	18.29M	173.49M	171.66M